COL1A1 Antibodies

Santa Cruz Biotechnology delivers a wide array of COL1A1 monoclonal antibodies for investigating collagen type I alpha 1, a crucial component of the extracellular matrix. COL1A1 Antibodies for COL1A1 are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). COL1A1 plays a vital role in providing structural support to tissues and is essential for bone and skin integrity. Abnormalities in COL1A1 expression are associated with several disorders, including osteogenesis imperfecta and fibrosis, making it a significant target for research in developmental biology and disease mechanisms. Understanding the function and regulation of COL1A1 is critical for advancing therapeutic strategies in connective tissue disorders. Researchers worldwide rely on COL1A1 monoclonal antibodies to explore fundamental questions about extracellular matrix composition and organization. COL1A1 monoclonal antibodies enable detailed investigation of tissue development, wound healing, and pathological conditions. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing our understanding of collagen biology and its impact on human health.